Targeting the Angiotensin II Type 1 Receptor in Cerebrovascular Diseases: Biased Signaling Raises New Hopes
The physiological and pathophysiological relevance of the angiotensin II type 1 (AT<sub>1</sub>) G protein-coupled receptor no longer needs to be proven in the cardiovascular system. The renin–angiotensin system and the AT<sub>1</sub> receptor are the targets of several class...
Main Authors: | Céline Delaitre, Michel Boisbrun, Sandra Lecat, François Dupuis |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-06-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/13/6738 |
Similar Items
-
The Role of β-Arrestin Proteins in Organization of Signaling and Regulation of the AT1 Angiotensin Receptor
by: Gábor Turu, et al.
Published: (2019-08-01) -
The AT<sub>1</sub>/AT<sub>2</sub> Receptor Equilibrium Is a Cornerstone of the Regulation of the Renin Angiotensin System beyond the Cardiovascular System
by: Mélissa Colin, et al.
Published: (2023-07-01) -
Metoprolol disrupts inflammatory response of human cardiomyocytes via β-arrestin2 biased agonism and NF-κB signaling modulation
by: Fabrizio Ricci, et al.
Published: (2023-12-01) -
Actions of Novel Angiotensin Receptor Blocking Drugs, Bisartans, Relevant for COVID-19 Therapy: Biased Agonism at Angiotensin Receptors and the Beneficial Effects of Neprilysin in the Renin Angiotensin System
by: Graham J. Moore, et al.
Published: (2022-07-01) -
Biased versus Partial Agonism in the Search for Safer Opioid Analgesics
by: Joaquim Azevedo Neto, et al.
Published: (2020-08-01)